Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;3(1):57-62.
doi: 10.1007/BF00176825.

Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule

W J Moriconi, S Taylor, M Slavik, R J Belt, C D Haas, B Hoogstraten

Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule

W J Moriconi et al. Invest New Drugs. 1985.

Abstract

A phase I trial of chlorozotocin was completed for a weekly times four dose schedule repeated every 8 weeks. Thrombocytopenia was the acute dose limiting toxicity. Nausea and vomiting were moderate to severe and dose related. Two cases of possible drug related irreversible nephrotoxicity were seen. Transient elevations of serum creatinine and mild proteinuria were noted. Also, transient elevations in SGOT were observed. One patient with a carcinoid tumor had a 60% reduction in his 5HIAA level after one course of therapy. The recommended dose for phase II clinical studies of chlorozotocin is 40 mg/m2 IV weekly for four weeks, repeated every 8 weeks.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1978 Jun;23 (6):712-22 - PubMed
    1. Blood. 1984 Apr;63(4):759-67 - PubMed
    1. Cancer Res. 1975 Mar;35(3):761-5 - PubMed
    1. Cancer Treat Rep. 1979 Jan;63(1):17-20 - PubMed
    1. Cancer Treat Rep. 1976 Jun;60(6):801-5 - PubMed

Publication types

MeSH terms